Literature DB >> 3321263

Epidemiology of hospital-acquired pneumonia.

P A Gross1.   

Abstract

Nosocomial pneumonia may account for a relatively small percent of all hospital-acquired infections, but it is associated with the highest mortality of all nosocomial infections. Risk factors include increasing age, thoracoabdominal surgery, presence of chronic lung disease, duration in hospital, immunosuppressive therapy, continuous ventilatory support, and means of payment. Among patients dying in the hospital, a nosocomial pneumonia was present in 40% and was causally related or contributed to death in 60% of nosocomially infected patients. Gram-negative bacilli, Staphylococcus aureus, and viruses are the most common etiologic agents. Changes in T lymphocytes with aging, alterations in the physiologic and anatomic defenses from trauma, disease, or aging and lack of appropriate infection control barriers predispose to development of pneumonia. Extra hospital charges of approximately $1,000 and four to five additional hospital days result. Analysis of pertinent epidemiologic data require understanding of clinical definition of pneumonia, laboratory methods used to analyze respiratory secretions, and methods of comparing added charges and length of stay.

Entities:  

Mesh:

Year:  1987        PMID: 3321263

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  4 in total

1.  Initial antimicrobial treatment of hospital acquired pneumonia in adults: A conference report.

Authors:  L A Mandell; T J Marrie; M S Niederman
Journal:  Can J Infect Dis       Date:  1993-11

Review 2.  Systemic antibiotic treatment of nosocomial pneumonia.

Authors:  K E Unertl; F P Lenhart; H Forst; K Peter
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

3.  Non-invasive mechanical ventilation in severe chronic obstructive lung disease and acute respiratory failure: short- and long-term prognosis.

Authors:  M Vitacca; E Clini; F Rubini; S Nava; K Foglio; N Ambrosino
Journal:  Intensive Care Med       Date:  1996-02       Impact factor: 17.440

Review 4.  Nosocomial pneumonia : rationalizing the approach to empirical therapy.

Authors:  Gunnar I Andriesse; Jan Verhoef
Journal:  Treat Respir Med       Date:  2006
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.